Taiwan-based vaccine maker Adimmune Corp. on Tuesday said it has signed an agreement with the World Health Organization (WHO) to receive early biological samples of emerging influenza variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Trump says he will discuss Taiwan with Xi at APEC
10/25/2025 04:33 PM - Sports
Taiwan's Olympics table tennis duo advances to WTT finals
10/25/2025 12:33 PM - Culture
Taiwan wins 5 first-place prizes at World Stage Design contest
10/25/2025 12:15 PM - Society
Taiwan headline news
10/25/2025 11:28 AM - Cross-Strait
Taiwan slams China for designating Oct. 25 'Taiwan Restoration' day
10/24/2025 11:09 PM